EU Pharma Strategy Offers Window For Regulatory Optimization

‘Very Significant’ Reforms Offer A Chance To Build On Pandemic Experiences

 
• By Dave Wallace

Attendees to Medicines for Europe’s Regulatory Affairs and Pharmacovigilance virtual conference heard that a window of opportunity to optimize the region’s regulatory landscape is now “wide open” with the advent of the new EU Pharmaceutical Strategy.

Optimization key keyboard computer
Optimizing the regulatory environment in Europe is key for the off-patent industry • Source: Shutterstock

The new EU Pharmaceutical Strategy has opened a window of opportunity “wide open” for the optimization of Europe’s regulatory environment, according to off-patent industry association Medicines for Europe.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Generics Bulletin